Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Xuanfei Zhike is a traditional Chinese herbal medicine formulation used primarily for the treatment of pediatric respiratory diseases, specifically acute bronchitis. It is typically provided as a syrup or granule and is developed to relieve symptoms such as cough and phlegm by "dispersing wind-heat" and promoting lung health, following principles of traditional Chinese medicine. The syrup formulation is in phase 3 clinical trials and is produced as a children's cold medicine targeting infectious and respiratory conditions. The mechanism of action is based on multi-component herbal ingredients believed to have anti-inflammatory, antitussive (cough-suppressing), and expectorant effects, though no specific molecular targets have been conclusively defined in biomedical literature. The developer and active organization is Qingdao Haichuan Innovative Bio-Natural Medicine Research Center[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiaoer xuanfei zhike.